Laboratory of Biogenomics, Department of Morphology, Health Sciences Center, Federal University of Santa Maria, 1000 Roraima Av., Building 19, Camobi, Santa Maria, RS, 97105-900, Brazil.
Laboratory of Biogenomics, Department of Morphology, Health Sciences Center, Federal University of Santa Maria, 1000 Roraima Av., Building 19, Camobi, Santa Maria, RS, 97105-900, Brazil.
Mult Scler Relat Disord. 2023 Mar;71:104515. doi: 10.1016/j.msard.2023.104515. Epub 2023 Jan 13.
Relapsing-remitting multiple sclerosis (RRMS) is the most common clinical course of multiple sclerosis (MS), characterized by a chronic inflammatory state and elevated levels of oxidative markers. Food supplements with potential anti-inflammatory, antioxidant and neuroprotective effects have been tested as possible adjuvants in the treatment of MS. In this sense, this pilot study was carried out with the aim of verifying whether a minimum daily dose of a guarana, selenium and l-carnitine (GSC) based multi supplement, mixed in cappuccino-type coffee, administered for 12 weeks to 28 patients with RRMS could differentially modulate oxidative blood markers (lipoperoxidation, protein carbonylation and DNA oxidation) and inflammatory blood markers (protein levels of cytokines IL-1β, IL-6, TNF-α, IFN-γ, IL-10, gene expression of these cytokines, and NLRP3 and CASP-1 molecules, and C-reactive protein levels). The results indicate that a low concentration of GSC is capable of decreasing the plasma levels of oxidized DNA and pro-inflammatory cytokines of RRMS patients. The results support further research into the action of GSC on clinical symptoms, not only in patients with MS, but also with other neurological conditions.
复发缓解型多发性硬化症(RRMS)是多发性硬化症(MS)最常见的临床病程,其特征为慢性炎症状态和氧化标志物水平升高。具有潜在抗炎、抗氧化和神经保护作用的食品补充剂已被测试作为 MS 治疗的可能辅助剂。有鉴于此,进行了这项初步研究,目的是验证每天摄入最低剂量的瓜拉那、硒和左旋肉碱(GSC)为基础的多种补充剂,混合在卡布奇诺咖啡中,连续给 28 名 RRMS 患者服用 12 周,是否能使氧化血液标志物(脂质过氧化、蛋白质羰基化和 DNA 氧化)和炎症血液标志物(细胞因子 IL-1β、IL-6、TNF-α、IFN-γ、IL-10 的蛋白水平、这些细胞因子的基因表达、NLRP3 和 CASP-1 分子以及 C-反应蛋白水平)发生差异调节。结果表明,低浓度的 GSC 能够降低 RRMS 患者的血浆氧化 DNA 和促炎细胞因子水平。结果支持进一步研究 GSC 对临床症状的作用,不仅在 MS 患者中,而且在其他神经疾病患者中也有作用。